Current Report Filing (8-k)
August 25 2017 - 04:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
August
24, 2017
Date
of Report (Date of earliest event reported)
Immune
Therapeutics, Inc.
(Exact
name of registrant as specified in its charter)
Florida
|
|
000-54933
|
|
59-3226705
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification No.
|
37
North Orange Ave, Suite 607, Orlando, FL
|
|
32801
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code
888-613-8802
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
Immune
Therapeutics, Inc. (the “Company”) has appointed Mr. Rudy Williams to serve as its Chief Operations Officer. There
was no prior arrangement between Mr. Williams and any Company representative prior to his appointment.
Rudy
Williams is the former president of International Engineering Services, Inc. (IESINC); one of the country’s largest minority
owned engineering service company in the early and late seventies, 1969-1985. He sold IES in 1985. In the mid-eighties, Mr. Williams
identified the need for a government affairs firm dedicated to small business issues and formed The Phoenix Group. The Phoenix
Group is a public affairs company that specializes in federal government, legislative representation, and internal relations.
Mr. Williams also created Direct Pharmacy Service, Inc. (DPSI) in the early nineties with his partner James Hill (now deceased).
DPSI became the largest Mail Order Pharmacy, operating from their facilities in the Southern sector of the U.S. The interface
with government regulations, rules extended to DPSI to become a Pharmacy Benefit Management Company which intensified relations
with federal government health care regulations. Mr. Williams has a BS/MS degree in Electrical Engineering; attended Tuskegee
Institute, Arizona State University and Massachusetts Institute of Technology (MIT).
Item
8.01 Other Events
On
August 24, 2017, the Company issued a press release announcing that its majority owned subsidiary, Cytocom, Inc., has appointed
Dr. John Abeles as its Chairman, Director and CEO. Dr. Abeles will also serve as a Senior Advisor to the Company.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are filed herewith.
Exhibit
No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
IMMUNE
THERAPEUTICS, INC.
|
|
|
|
Date:
August 25, 2017
|
By:
|
/s/
Noreen Griffin
|
|
|
Noreen
Griffin, CEO
|
Immune Therapeutics (PK) (USOTC:IMUN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Immune Therapeutics (PK) (USOTC:IMUN)
Historical Stock Chart
From Mar 2023 to Mar 2024